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Background: Vancomycin-resistant enterococci are pathogenic bacteria that 
attenuate antibiotic sensitivity by producing peptidoglycan precursors that 
terminate in D-Ala-D-lactate rather than D-Ala-D-Ala. A key enzyme in effecting 
antibiotic resistance is the metallodipeptidase VanX, which reduces the cellular 
pool of the D-Ala-D-Ala dipeptide. 
Results: We constructed eleven mutants, using the recently determined VanX 
structure as a basis, to investigate residue function. Mutating Asp1 42 or Serl 14 
showed a large effect principally on KM, consistent with roles in recognition of 
the D-Ala-D-Ala termini. The drastic reduction or absence of activity in the Arg71 
mutants correlates with a role in the stabilization of an anionic tetrahedral 
transition state. Three residues of the Escherichia co/i D-Ala-D-Ala ligase (Ddl), 
Glul5, Ser 281 and Arg255, are similarly conserved and have equivalent 
functions with respect to VanX, consistent with a convergent evolution of active 
sites to bind D-Ala-D-Ala and lower energy barriers for formation of the 
tetrahedral intermediate and transition states. In the N-acyl-D-Ala-D-Ala 
carboxypeptidase VanY, all active-site residues are conserved (except for the 
two responsible for recognition of the dipeptide amino terminus). 
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Conclusions: The mutagenesis results support structure-based functional 
predictions and explain why the VanX dipeptidase and Ddl ligase show narrow 
specificity for the D,D-dipeptide substrate. The results reveal that VanX and Ddl, 
two enzymes that use the same substrate but proceed in opposite directions 
driven by distinct cofactors (zinc versus ATP), evolved similar architectural 
solutions to substrate recognition and catalysis acceleration. VanY sequence 
analysis predicts an active site and mechanism of reaction similar to VanX. 
Introduction 
The worldwide resurgence of infectious diseases, largely 
due to the appearance of antibiotic-resistant bacteria, is a 
serious medical problem [l-3]. Vancomycin-resistant 
enterococci (VRE) have become recognized as important 
opportunistic human pathogens over the past decade. 
Increased reliance on the glycopeptide antibiotic van- 
comycin to treat enterococcal infections and those 
caused by the dreaded methicillin-resistant Stap/zylococcus 
aurezlS (MRSA) [4] has not only caused a rise in clinically 
significant resistance and mortality from VRE, but also 
represents a looming infectious catastrophe for MRSA 
[d-8]. In the most prevalent clinical phenotypes of van- 
comycin resistance, VanA and VanB [8], bacteria have 
developed a strategy for reprogramming cell wall biosyn- 
thesis to new peptidoglycan precursor termini, which 
exhibit dramatically lower affinity for vancomycin. This 
paradigm of bacterial adaptation requires expression of 
the genes aanR, vans, aanH, canA and aatzX (using VanA 
phenotypic nomenclature, Figure 1) [9] to produce pepti- 
doglycan chain precursors terminating in D-alanyl-D-lactate 
(D-Ala-D-lactate) in place of D-alanyl-D-alanine (D- 
Ala-D-Ala), resulting in a lOOO-fold decrease in van- 
comycin binding affinity and in unimpeded peptide 
strand cross-linking. The outcome is a mechanically 
strong cell wall whose synthesis is not inhibited by gly- 
copeptides [lo]. Vans and VanR act as a two-component 
regulatory system to mediate antibiotic-induced tran- 
scription of the genes vanH, nad and uanX, whose prod- 
ucts act sequentially (VanH, VanA) to synthesize the 
depsipeptide D-Ala-D-lactate in place of the normal D- 
Ala-D-Ala dipeptide [ll,lZ]. VanX is a zinc-containing 
D,D-dipeptidase that hydrolyzes D-rZla-D-Ala but not D- 
Ala-D-lactate, allowing the D,D-depsipeptide to accumu- 
late and become incorporated in the growing 
peptidoglycan termini [13,14]. In the Van,4 VRE pheno- 
type, these genes are clustered on a transposon with two 
genes associated for transposition functions (o$ and 
o$‘) and two other oan genes, nanY and aanZ [9] 
(Figure 1). Although the VanE; D,D-carboxypeptidase is 
not essential for a high level of resistance in the VanA 
VRE phenotype, it is believed to contribute moderately 
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Figure 1 
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Schematic representation of the genes required for a high level of 
resistance to vancomycin in the VanA phenotype found within the 
transposon Tn 1546 [9]. The vanR, vanS, vanh’. vanA and vanX genes 
are essential for a high level of resistance; the vanrand vanZ genes 
are nonessential. orfl and orf2 encode proteins required for 
transposition. 
to the resistance (e.g. in the VanB phenotype) by remov- 
ing the terminal D-Ala from the newly synthesized 
UDP-muramyl-L-Ala-D-Glu-L-Lys-L>-Ala-II-Ala that has 
escaped the VanX route [ 151, snnZ has no identified func- 
tion and it is not essential for resistance. 
The origin of the glycopeptide resistance genes in entero- 
cocci has been an issue since their discovery: a first 
glimpse at a possible source came with the recent detec- 
tion of a WZ~HAX gene cluster similar to that found in VRE 
in the glycopeptide antibiotic-producing Strepto7ByceJ toyo- 
caensis and Amycolatopsis orientalis [ 161. The demonstration 
that the VanX homolog (StoVanX) encoded by the S. toyo- 
caensis s?anHAX gene cluster possesses both the anticipated 
D-Ala-D-i\ia dipeptidase activity and lacks &Ala-r>-lactate 
depsipeptidase activity [ 171 suggests a conserved mecha- 
nism for the observed intrinsic resistance of the antibiotic 
producers to the vancomycin class of glycopeptides. As 
s. toyocaensis also possesses a D-Ala-D-Ala ligase [18], the 
uanHAX genes may be switched on transcriptionally as the 
host commences antibiotic biosynthesis, allowing cell-wall 
termini to be reprogrammed to effect immunity to van- 
comycin in a timely fashion. Such a regulatory circuit (yet 
to be verified experimentally) is consistent with the view 
that antibiotic-resistance genes might have coevolved with 
the antibiotic-biosynthesis genes. 
VanX homologs have also been detected in the gram-neg- 
ative bacterium Eschetichia coli (EcoVanX) and Sy’nrchorys- 
tis sp. (SynVanX), which have no need for defense against 
glycopeptide antibiotics (the outer membranes of E. co/i 
and Syne&~~~tic sp. are impermeable to vancomycin) [17]. 
In E. cob, the ecooanX gene is found clustered with a 
putative dipeptide permease system that permits import 
of D-Ala-D-i\la into the cell [17]. The consecutive action 
of ecoaanx, pyruvate oxidase and the membraneous I)- 
amino acid dehydrogenase would permit an energy gener- 
ating role for this enzyme couple upon induction of the 
ecoaanX and downstream permease genes by the station- 
ary phase transcription factor CY under starvation condi- 
tions. A possible source of periplasmic D-Ala-D-Ala could 
be r,,D-meso-diaminopimelic acid (AZpm)-A2pm transpep- 
tidation, which increases during stationary phase [17]. 
VanX and II-Ala-o-Ala ligase (Ddl) catalyze antagonistic 
reactions - Ddl operates in the dipeptide biosynthetic 
direction. whereas VanX operates in the hydrolytic direc- 
tion (Figure 2a). Because enzymes catalyze reactions in 
both directions (although the equilibria might be heavily 
biased in one direction. in this instance Ddl is driven in the 
contrathermodynamic direction by coupling ,4TP hydroly- 
sis to amide-bond formation), the two opposing enzymes 
have many of the same requirements. In this case, they 
must recognize the ground state for D-Ala-n-Ala as sub- 
strate (VanX) or product (Ddl), and differentially recognize 
the two 1,-,41a monomers as electrophile and nucleophile 
(Ddl) or as first leaving group (VanX). Ddl and VanX must 
form and stabilize tetrahedral adducts at the amide link of 
D-Ala-D-Ala to lower activation barriers and speed up catal- 
ysis. To perform their related tasks, one enzyme uses ,4TP 
cleavage to drive amide-bond synthesis (Ddl), tvhereas the 
other employs zinc to activate bound water for hydrolysis of 
I>-Ala-D-Ala (VanX). Despite the difference in cofactor 
usage, one might expect the catalytic inventory for the 
l&Ala-D-Ala ligase and the n-Ala--D-Ala dipeptidase active 
sites to be analogous and fulfill equivalent functions. To 
recognize D-Ala-D-Ala (as substrate or nascent product) one 
would expect an active-site residue in each enzyme to 
hydrogen bond and/or charge pair with the a-NH,+ of 
D-Ala-n-Ala (most likely Enz-COO-) and a corresponding 
recognition of the substrate-COO- to occur as well (Enz- 
OH utilized). To stabilize the incipient charge that devel- 
ops in the transition state as the planar sp2 carbonyl moiety 
is transformed to the sp” tetrahedral anion (and vice versa; 
Figure 2a) one would expect an enzyme active-site cation 
properly placed to stabilize the developing negative charge 
(e.g. a multidentate arginine-sidechain: Figure Zb). 
The recent crystal structure determination of enterococcal 
VanX [19] and the existing X-ray structure of E. cob 
D-Ala-D-Ala ligase (DdlB) [20] with tetrahedral phosphinate 
transition-state analogs (Figure 3) as well as with substrate 
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Reactions catalyzed by the Ddl and VanX enzymes. (a) DdlB and VanX Both enzymes must form and stabilize similar tetrahedral adducts at 
catalyze antagonistic reactions. The Ddl ligase runs in the amide the amide link of the D-Ala-o-Ala molecule, however. (b) Despite their 
synthetic direction and has to consume a molecule of ATP to allow the difference in cofactor usage, similar sidechains between the two 
reaction to proceed. In contrast, VanX runs in the hydrolytic direction enzymes are predicted for ground state and specific binding, and 
and uses a zinc atom and a water molecule to accomplish its task. transition-state stabilization. 
for VanX, has given us a view of the active-site geometry 
and the disposition of active-site sidechains. The VanX 
structure, in particular. predicts specific enzyme 
sidechains that could fulfill the requirements shown in 
Figure 2 for both ground-state recognition and specific 
binding, as well as for transition-state stabilization. To test 
these predictions we have generated mutants of VanX at 
seven different positions and evaluated the catalytic effi- 
ciency of the mutant enzymes. We compare equivalent 
sidechain functions in Ddl. Sequence analysis of VanY and 
VanX, in addition to comparison with the X-ray structure 
of the zinc-dependent u-Ala-+-Ala carboxypeptidase (a 
VanY homolog) from Strepfomq’ces ahs G (Ddp) [Zl]. has 
allowed us to predict an equivalent organization of the 
active sites of these enzymes for recognition and hydroly- 
sis of either the ,V-acyl-D-Ala-[,-Ala (\?anY and Ddp) or 
I>-Ala-n-Ala (VanX). 
Results 
Design and production of VanX mutants 
The recently reported X-ray structure of enterococcal 
VanX [19] bound to its substrate I,-Ala-[)-Ala and phosphi- 
nate, a reaction intermediate analog [ZZ], guided the initial 
mutant construction design to test for residue function. At 
the amino terminus of bound r)-Ala-n-Ala or phosphinate, 
three VanX residues (Tyr21, Asp142 and Asp123) were 
found in close proximity for hydrogen bonding with the 
substrate/analog cx-IKHj+ (Figures 3 and 4). Asp123 WiS 
shown previously to be a critical ligand for zinc binding 
[23]. Tyr21 was mutated to phenylalanine and Asp142 to 
an alanine or asparagine residue. Serll.~ has been proposed 
to form a hydrogen bond at the carboxyl end of bound 
D-Ala-u-Ala, whereas it is the sidechain of Serl14 that 
appears to play this role in the case of bound phosphinate. 
Both Serl14 and Serll5 were changed singly to alanine. 
Arg71 is a candidate to stabilize the anionic tetrahedral 
adduct and its associated transition states so it was mutated 
to an alanine, histidine or lysine residue. Tyr35 and Asp68 
are in position to form a hydrogen-bond triad with Arg71 
and could serve to orient ,4rg71. Tyr35 was mutated to 
phenylalanine and Asp68 to alanine or asparagine. We 
showed previously that VanX retains full activity as a 
I,,t)-dipeptidase when fused to maltose-binding protein 
(MBP) [23], so the kinetic data reported in Table 1 were 
obtained using the intact MBP-VanX mutant fusion pro- 
teins in each case. 
Characterization of MBP-VanX mutants as D-Ala-D-Ala 
dipeptidases 
Table 1 lists the steady-state kinetic data of various 
MBP-VanX mutants. For a zinc-dependent peptide-bond 
hydrolase such as VanX, catalytic efficiency will be deter- 
mined by optimizing the orientation of the substrate 
t>-Ala-n-Ala and water as ligands at or around the catalytic 
zinc and lowering barriers for reaction. Coordination of the 
substrate I)-Ala-[)-Ala and the tetrahedral adducc to zinc 
are anticipated and supported by the X-ray data [19]. 
Three categories of effects were observed for the VanX 
mutants: modest change: TyQl+Phe, Tyr3S-+Phe and 
Serl lS-+Ala; intermediate change: Serl l++Ala: and large 
change: the AspllZ, Arg71 and ,4sp68 mutants. 
Modest effects: TyRl+Phe, Tyr35+Phe and Serl15+Ala 
The mutant TyrZl-+Phe is only decreased 125fold in 
catalytic efficiency (k,,,/K,,). which mainly results from a 
38-fold increase in K,,. The loss of the phenolic hydroxiyl. 
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Figure 3 
(a) (W 
Crystal structure comparison of the active-site 
residues of (a) VanX and (b) Ddlf3 with bound 
phosphinate [191 and phosphorylphosphinate 
[201, respectively. Glul5, Ser281 and Arg255 
in DdlB are similarly placed with respect to 
the transition-state analog and are functionally 
equivalent to Asp1 42, Serl14 and Arg71 in 
VanX. Serl50 orients Glul5 in DdlB as TyrPl 
orients Asp1 42 in VanX. TyrPl is also 
hydrogen bonded to the substrate cx-NH,+. 
The arginine residues stabilize the transition- 
state intermediate with help from Lys215 in 
DdlB and the zinc atom in VanX. Arg71 in 
VanX is oriented by Asp68 and Tyr35. DdlB 
uses Lys2 15 for phosphate transfer, whereas 
VanX uses the similarly placed Glu181 to 
abstract a proton from a water molecule for 
subsequent attack on the carbonyl group of 
the substrate. The zinc ligands are His1 16, 
Asp1 23 and His1 84. 
abrogating a medium-length hydrogen bond (3.2 A) to the 
cc-IKH,+ group of the dipeptide has only a modest effect, 
suggesting that this is not a crucial interaction by itself. 
The second tyrosine residue, Tyr35, is part of a triad with 
the Arg71 and Asp68 residues that probably form hydro- 
gen bonds with each other to orient the guanidinium 
sidechain of Arg71 to stabilize the incipient negative 
charge of the tetrahedral transition state after the attack of 
the zinc-coordinated water molecule (Figure 4). Disrup- 
tion of Tyr35 hydrogen-bonding potential (Tyr35-+Phe) 
is noticeable but slight (there is a Zl-fold increase in K,,). 
Figure 4 
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Schematic diagram of the active-site residues in the enterococcal VanX 
complexed with the phosphinate transition-state analog. Possible 
interactions are shown by dashed lines. Hydrogen bond distances are 
indicated. The residues colored blue were investigated previously 1231. 
The residues colored red were investigated in this study. 
The Asp68 sidechain is probably the primary determinant 
controlling the orientation of Arg71 (see below). 
The Serl lS--+Ala mutation has a very small effect. The Khl 
increases by a factor of two but because the k,,, increases 
threefold, the mutant is actually a better catalyst than wild- 
type VanX. This result turns out not to be so surprising 
because this residue is not conserved in other VanX 
homologs (except for the VanX from the type B resistance) 
[17]. Serl15 is, therefore. not a crucial substrate-binding 
element and the Serllj-+Ala mutant serves as a good 
control for interpreting the Serl14+Ala mutant. 
intermediate effect: Serl14+Ala 
The Serll4-+Ala mutant is a 2500-fold less efficient 
enzyme with only a L.&fold decrease in k,,, but a 2000-fold 
increase in k;,. The loss of enzyme efficiency is entirely 
due to loss of substrate binding, as would be expected for a 
ground-state effect in substrate COO- recognition. The 
element for binding of the carboxylate end of the substrate 
is therefore Serll4 as obsen,ed in the VanX structure with 
bound phosphinate and not SerllS as was observed with 
bound II-Ala-n-Ala [ 191. 
Large effects: Arg71, Asp142 and Asp66 mutants 
.4rg71-+Ala and Arg71-+His mutants show no detectable 
dipeptidase activity over a time course of 12 h, suggesting 
that Arg71 is crucial. The Arg71+Lys mutant has 
detectable activity but shows a 1.7 x 10h-fold decrease in 
catalytic efficiency, due to a 2750-fold increase in K,, and a 
670-fold reduction in kcaf. These results suggest substantial 
loss of transition-state recognition/stabilization. ‘I’he Arg71 
mutants are most seriously affected, consistent with a key 
role in catalytic function. Neither the Arg7l+Lys nor the 
Arg’ll+His basic sidechains seem to be able to achieve an 
orientation that can substitute for the placement of Arg71. 
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Table 1 
Kinetic parameters of purified MBP-VanX mutants fusion proteins using p-Ala-p-Ala as substrate. 
Protein kc,, (s-‘I* Decrease (x-fold) KM hM) increase (x-fold) k,,lK, (s-ImM-I) Decrease (x-fold) 
Wild type 26 
TyrPl -+Phe 7.8 
Asp1 42-+Ala 0.037 
Asp1 42+Asn 0.30 
Serll4-+Ala 22 
Serll5+Ala 73 
Arg71 +Ala nd 
Arg71 +His nd 
Arg7 1 +Lys 0.041 
Asp68-tAla 0.097 
Asp68-+Asn 0.12 
Tvr35-+Phe 10 
3 
703 
87 
1.2 
0.36 
38 
81 
1200 
2000 
2 
125 
58000 
105000 
2500 
0.71 
- 
634 
270 
217 
2.6 
0.080 
3.0 
6.5 
96 
160 
0.16 
nd 
nd 
220 
60 
5.0 
1.7 
2750 
750 
63 
21 
330 
2.6 
0.0056 
0.0031 
0.13 
460 
nd 
nd 
0.00019 
0.0016 
0.024 
5.8 
1700000 
200000 
14000 
56 
MBP-VanX samples were prepared from cells grown in LB media cadmium-ninhydrin method (see the Materials and methods section). 
supplemented with 200 PM ZnSO,. ‘Dipeptidase activity was assayed Protein concentrations were determined from the corrected absorbance 
by measuring the production of o-Ala using the modified at 280 nm in H,O [40]. nd, no detectable activity over 12 h. 
The ,4rg142+Ala and Arg142-+,4sn mutants were con- 
structed because the X-ray structure of VanX shows that 
Asp142 is within 2.8 w of the D,D-substrate’s a-NH,+, con- 
sistent with participation in ground-state recognition 
(Figure 4). The Aspl4Z+Asn mutant is decreased only 
87-fold in k,,, but is increased 1200-fold in Khl, suggesting 
that Asn142 might still be able to hydrogen bond with the 
D,D-substrate a-NH,+. The k,,, of the Asp142+Ala 
mutant is decreased 700-fold, an order of magnitude worse 
than the Asp142-+;2sn mutant. It is not clear why the K1, 
is only increased 81-fold, however. These effects in k,,, 
and KR, have not been subdivided into effects on micro- 
scopic rate constants, so we make no further interpretation 
about effects on elementary steps. 
When the importance of Asp68 was examined, with the 
Asp68+Asn and Asp68--+Ala mutants, substitution of 
aspartate by asparagine preserves more function than the 
aspartate to alanine switch. Here, both mutants have a 
ZOO-300-fold decrease in k,,, but the Asp68jAsn mutant 
only has a 63-fold increase in K,,, whereas in the 
Asp68+Ala mutant, the K,,, was 750-fold worse. The VanX 
crystal structure shows that Asp68 is the central residue in 
the Arg71-Asp68-Tyr35 hydrogen-bonding triad. Presum- 
ably the asparagine sidechain in the Asp68+Asn mutant 
retains more contact with Arg71 than does the alanine 
sidechain in the ,4sp68+Ala mutant, assisting in produc- 
tive orientation of Arg71 for transition-state stabilization. 
TyrZl+Phe, had an increased ability to hydrolyze 
I>-lactyl-D-Ala. The AsplilZ+Asn and Asp142+Ala 
mutants showed a 60- and 160-fold increase in peptidase 
activity, respectively, compared with the wild-type 
enzyme, which has a barely detectable k,,JK1, of 
2 x lo-’ m,\l-‘s-l, a factor of 10’ worse than for I,-Ala-r>- 
Ala (Table 2). The Tyr2l-+Phe VanX mutant shows a 
much larger effect with an increase of 4300-fold in cat- 
alytic efficiency over the wild-type enzyme. For this 
mutant, II-Ala-u-Ala is only 30-fold better by k,,,/K:,, crite- 
rion than D-lactyl-D-Ala. This 30-fold difference is almost 
entirely due to K,,. The k,,, of TyrZl+Phe for o-lactyl- 
o-Ala cleavage is only sixfold lower than the wild-type 
enzyme for its natural substrate, D-Ala-D-Ala, suggesting a 
similar substrate orientation for peptide cleavage in each 
enzyme. In wild-type VanX Ty21, which hydrogen bonds 
to Aspl42, might exclude D-lact+II-.t\la by means of elec- 
trostatic repulsion between two oxygens. The Asp142 
mutants have only a twofold increase in catalytic effi- 
ciency for n-Ala--u-Ala than I>-lactyl-D-Ala. Again removal 
of electron density close to the binding site for D-Ala- 
n-Ala a-NH,+ allows better binding of the uncharged 
D-lactyl-D-Ala substrate. Interestingly, in DdlB? a 
D-lactyi-D-141a ligase activity was detected in the 
GlulS+Gln mutant [24]. Both Glu15 in DdlB and Asp142 
in VanX are involved in the a-&H,+ recognition of the 
substrate n-Ala for DdlB and D-Ala-D-Ala for VanX. 
Discussion 
Detection of novel activity in mutant proteins 
We examined the mutant proteins for ‘gain of function’ 
novel activities by testing other potential enzyme sub- 
strates. In no case was ;V-acetyl-rj-Ala-D-Ala a substrate, 
even for the TyrZl-+Phe mutant, but the reverse regioiso- 
mer of D-Ala-D-lactate, the n-lactyl-D-Ala amide (which 
lacks an a-NH,+ group) showed an interesting substrate 
profile. Three mutants, Asp142-+Ala, Aspl4Z-+Asn and 
Metalloproteases have been a successfully targeted for 
rationally designed therapeutic agents in other biological 
contexts (e.g. angiotensin converting enzyme inhibitors), 
suggesting that VanX is a prime candidate for design of 
inhibitors to combat VRE. In an earlier study of the zinc- 
dependent metallodipeptidase enterococcal VanX (VanA- 
type resistance). we identified, using mutagenesis, residues 
His1 16, Asp123 and His184 as probable zinc-coordination 
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Table 2 
Kinetic parameters of purified MBP-VanX mutants fusion 
proteins using D-lactyl-D-Ala as substrate. 
Protein k (s-‘)* cat 
Wild type 
TyrPl +Phe I”3 
Asp1 42+Ala 0.066 
Asp142-+Asn 0.18 
K,,,, WI) 
1; 
20 
150 
katlKrv, 
(s’mM-‘) 
0.000021 
0.091 
0.0033 
0.0012 
increase 
(x-fold) 
4300 
160 
60 
*See comments in Table 1. ns, no saturation. 
ligands and Glu181 as the probable general base for depro- 
tonation of the zinc-coordinated water molecule that sub- 
sequently attacks the I>-Ala-II-Ala substrate [23]. The 
recent crystallographic structure determination of entero- 
coccal VanX has confirmed these assignments [ 191. 
Similar recognition features for D-Ala-D-Ala ligase and 
D-Ala-D-Ala dipeptidase 
A comparison of the active-site organization for substrate 
and transition-state recognition by the ligase Ddl and the 
hydrolase VanX has been enabled by X-ray structures with 
tightly binding inhibitors, phosphinate for VanX and phos- 
phorylated phosphinate for Ddl. that built on our earlier 
mechanistic studies of each enzyme [Z&25]. The bound 
phosphinate ligands in each enzyme are taken to be stable 
analogs of the two tetrahedral intermediates (Figure Za) 
and so have suggested orientations of the corresponding 
reaction intermediate in the active site of each enzyme. 
Figure 3 shows a remarkable correspondence of orienta- 
tion of the same three types of sidechains for the same 
three functions in the ligase and dipeptidase active site: 
Glu15 (Ddl) versus Asp142 (VanX) for hydrogen 
bonding/charge pairing to the positively charged amino 
group of tetrahedral adduct phosphinate analogs; Ser281 
(Ddl) versus Serl1-l (VanX) for equivalent hydrogen 
bonds to the carboxyl end of the r),r,-analog; and ArgZSS 
(Ddl) versus Arg71 (VanX) for binding to the tetrahedral 
phosphinate oxygen (analagous to the tetrahedral adduct 
of the substrate) for transition-state/tetrahedral-adduct sta- 
bilization. In Ddl, Glu1.5 is oriented by SerlSO and Tyr216 
in a hydrogen-bond network. In VanX Asp142 is similarly 
oriented by Tyr21. hlutation of either SerlSO or Tyr216 in 
Ddl [Zj] or Tyr21 in VanX, has only modest effects on cat- 
alytic efficiency. In contrast, mutation of Glu15 in Ddl 
[25] or Asp142 in VanX has a pronounced effect on cat- 
alytic activity. Mutations at Ser281 in Ddl [25] or Serll4 
in VanX also have a substantial effect on substrate recog- 
nition as predicted. The Arg255+Ala Ddl mutant experi- 
enced at least a 2000-fold decrease in k,,,, at the noise 
level of the assay [25], which parallels the crucial role of 
Arg71 demonstrated here for VanX catalysis. 
It appears that a parallel strategy evolved in these other- 
wise quite different enzymes to provide, first, a specific 
binding pocket that recognizes only the unmodified 
D,D-dipeptide and, second, to stabilize developing anionic 
charge arising from rehybridization of the substrate amide 
carbonyl in the tetrahedral adduct. The other elements of 
the catalytic apparatus of each enzyme have evolved differ- 
ently. The l&se runs in the amide synthesis direction and 
requires hydrolysis of one molecule of ATP to drive that 
equilibrium, mechanistically activating the y-phosphoryl 
for attack by the first D-Ala (Figure 2a). The Lys215 of Ddl 
is required to act as a charge shield for the negative charge 
on the p of ATP to lower electrostatic repulsions in the 
catalytic instant of phosphor);1 transfer. No such function 
exists in VanX and there is no equivalent residue. There is, 
instead, a zinc atom in the VanX active site poised to inter- 
act with the bound substrate’s dipeptide carbonyl group 
and to coordinate a water molecule that will attack the 
amide bond. VanX needs a general base to activate the 
zinc-water complex, a function that is provided by Glu181 
(Figure 3). There is no comparable requirement in Ddl 
and therefore no comparable general base. The polarity of 
Lys215 in Ddl (cationic) and Glu181 in VanX (anionic) is 
therefore reserved for the two specific and differentiated 
jobs that these opposing enzymes have to perform. 
VanY and Ddp: two N-acyl-D-Ala-D-Ala carboxypeptidases 
with similar active-site residues equivalent to VanX 
The identification of residues for zinc coordination in the 
VanX enzyme has revealed a new family of zinc proteases 
that uses the novel consensus sequence SxHxxGxAxD, 
where aspartate and histidine residues are zinc ligands (the 
third and fourth ligands to zinc are a histidine several 
residues downstream in the primary sequence and water) 
[23]. The VanY and Ddp enzymes both have this consensus 
‘zinc motif [23] (although the VanY has yet to be validated 
for zinc content, its activity was shown to be dependent on 
divalent ions [26]) and act analogously on D-.Ala--I>-!Lla pep- 
tides as carboxypeptidases. VanY and Ddp differ from 
VanX in that they act on ;V-acylated-D,t>-peptide, and VanY 
shows activity towards the depsipeptide N-acyl-n-Ala-r>- 
lactate [27]. Structural comparison of VanX and Ddp 
revealed a strong homology in and around the active site 
[lY]. The zinc ligands, the serine residue for recognition of 
the terminal carboxylate moiety of D-.Ala-D-L41a and the 
arginine residue for stabilization of the transition state are 
structurally conserved in Ddp and VanX (Figure 5,). In 
Ddp a histidine residue apparently replaces Glu181 of 
VanX as catalytic base for water activation. The overall root 
mean square deviation value for superimposition of the 
sidechains of the zinc ligands, glutamate/histidine, serine 
and arginine residues is 1.03 A. The key .4sp68-Arg71 
hydrogen bond interaction of VanX is mimicked by an 
Arg138-A4sn143 interaction in Ddp. 
Primary sequence analysis suggests that the two enterococ- 
cal proteins VanY and VanX are more closely related than 
Ddp is to either VanX or VanY. We predicted previously 
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Figure 5 
Structural comparison of the active-site 
arrangements of VanX with bound phosphinate 
with Ddp. (a) Stereo diagram of the structural 
alignments of active-site residues of VanX (red) 
and Ddp (yellow). The zinc atoms are shown in 
red (VanX) and yellow (Ddp) and the 
phosphinate bound to VanX is orange. The 
alignment was performed on the sidechains 
shown, except for Asp68 (VanX) and Asn143 
(Ddp), using the program Cluanta@ (Molecular 
Simulations Inc.). (b) VanX and (c) Ddp surface 
electrostatic potential representation. Both 
proteins are positioned so that the conserved 
active-site residues highlighted in (a) are 
similarly oriented. The Ddp active site forms a 
channel on the surface. The VanX active site is 
in a pocket. The view of VanX has been cut 
away to reveal the active site and the bound 
phosphinate. The position of the active-site 
residue arginine (transition-state stabilization), 
aspartate (zinc ligand), serine (carboxylate 
recognition) and glutamatelhistidine (catalytic 
base) are indicated by arrow boxes using 
single-letter amino-acid code. The position of 
the other two zinc ligands (histidine residues) is 
approximated by the blue color surrounding the 
zinc atom (white), which is partially buried in 
both structures. The calculations were 
performed using GRASP (431 with a water 
probe radius of 1.4 A and electrostatic potential 
ranging from blue (+50 kt/e) to red (-50 kt/e). 
the catalytic glutamate residue (Glu’2.38) and zinc ligands 
(His188, Asp195 and His241) for the enterococcal VanY [23] 
(Figure 6). A BLAST search (http://www.ncbi.nlm.nih.gov/) 
detected seven additional bacterial homologs to VanY, 
including VanY from the VanB VRE phenotype (but did 
not rank Ddp as a homolog), and has allowed us to identify 
potential active-site residues. In all cases the Arg-(Asn/Gln) 
pair is conserved, which is indicative of a similar role for the 
arginine of VanY in transition-state stabilization. Another 
similarity is the conservation of the equivalent of the VanX 
active site Trp197 [19] in all VanY and VanX homologs in 
an E(P/W)WH motif. This tryptophan residue is found in 
proximity to and is believed to interact with the transition- 
state adduct [19]. The serine residue just upstream of the 
first histidine ligand to zinc (SxHxxGxAxD), Ser186 in 
VanY, is strictly conserved in the VanY family and predicted 
to be structurally equivalent to Serl14 in VanX or Ser152 in 
Ddp. This serine is functionally responsible for recognition 
of the terminal carboxylate moiety of the muramyl-L-iila- 
D-Glu-L-Lys-D-Ala-D-Ala substrate (Figure 6). The ques- 
tion arises, given the highly conserved architecture of 
active-site residues in VanX and VanY zinc carboxypepti- 
dases (Figure 6) as to how the differential recognition of a 
free amino group (as in VanX) versus an lv-acyl amino group 
(as in VanY) is achieved when scanning potential D-Ala- 
D-Ala substrates. The Tydl and Asp142 residues that 
recognize the a-NH,+ group in free D-Ala-D-Ala are not 
preserved in the VanY sequences. Their absence in the 
Ddp structure provides a channel for accommodation of an 
.v-acyl chain that would be blocked off in VanX 
(Figure jb,c). Aside from the residues highlighted in 
Figure 6, VanY and VanX show very little sequence 
homology, perhaps suggesting convergent evolution to a 
common catalytic geometry for binding and hydrolysis of 
the D,D-dipeptide moiety. Our analysis predicts that phos- 
phinates will be potent inhibitors of VanY and might act 
synergistically with VanX inhibitors, but does not yet indi- 
cate why VanY (but not VanX) has detectable Il,D-dep- 
sipeptide hydrolase activity. The homology between the 
VanY homologs outside the sequences highlighted in 
Figure 6 is very low. 
Reaction mechanism of D,D-peptidase 
The reaction mechanism of zinc proteases has been thor- 
oughly investigated for thermolysin [28-301 and car- 
boxypeptidase A enzymes [31,32] as representative zinc 
proteases (see [33] for review). Two variations for zinc-cen- 
tered mechanisms have been proposed: the zinc hydroxide 
and the reverse protonation mechanisms (see [33] for 
review). In the zinc-hydroxide mechanism, the zinc ion 
functions in two ways; it polarizes the substrate carbonyl 
group and facilitates deprotonation of the bound water 
nucleophile [33]. A proximal sidechain carboxylate group 
shuttles a proton from the zinc-bound water nucleophile to 
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Figure 6 
(W 
VanX : 
VanY : 
UDP-Muramyl-L-Ala-D-Glu-L-Lys-= 8 
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(a) Sequence alignment of VanY and VanX homologs and Ddp around Identity and similarity are denoted by dark and light gray background. 
the active-site residues. VanX,, Enterococcus faecium VanX; VanX,, 
E. faecalis VanX homolog; StoVanX, Streptomyces toyocaensis VanX 
homolog; EcoVanX, Escherichia co/i VanX homolog; SynVanX, 
Synechocystis sp. PCC6803 VanX homolog; VanY,, E. faecium VanY; 
VanYa, E. faecalis VanY homolog; BstVanY,, first Bacillus subtilis 
VanY homolog; BstVanY,, second B. subtilis VanY homolog; 
BbuVanY, Borrelia burgdorferiVanY homolog; TpaVanY. Treponema 
pallidurn VanY homolog; SynVanY,, first Synechocystis sp. PCC6803 
VanY homolog; SynVanY,, second Synechocystis sp. PCC6803 VanY 
homolog; Ddp, Sfreptomyces a/bus G o-Ala-o-Ala carboxypeptidase. 
The zinc ligands are yellow, the catalytic base (glutamine/histidine) and 
transition-state residues (arginine) are red, the carboxylate-end-binding 
residue is green, the arginine-orientation residues are purple and the 
cc-NH,+-binding residues are blue; all are shown in (b) the schematic 
diagram. The asterisk indicates potential functional residues required 
to recognize the extended substrate in the VanY family (serine, 
tryptophan and tyrosine residues). The alignment was performed using 
the CLUSTAL W method [441 on the entire VanY homolog sequences. 
The sequence of Ddp was aligned manually. The VanX sequence 
alignment has been published previously [17]. 
the leaving group. In contrast, the reverse protonation 
mechanism suggests that the zinc-bound water ligand will 
have to be protonated in order to be replaced by the car- 
bony1 group of the substrate [30]. In this case, the con- 
served carboxylate-containing residue would play only a 
charge-neutralization role [32]. In thermolysin, a hiscidine 
residue would act as general base to activate the water 
nucleophile, whereas in carboxypeptidase A, this role would 
be played by the carboxylate group of the substrate [30,32]. 
The active-site architecture of a VanX-D-Ala-D-Ala 
enzyme complex is closer to that of carboxypeptidase A 
than thermolysin, by having a free carboxylate group of the 
substrate in proximity to the cleavage site and also the tetra- 
hedral intermediate-stabilizing arginine residue (Arg71). In 
thermolysin, the arginine residue is replaced by tyrosine 
and histidine residues and there is no substrate carboxylate 
group near the cleavage site. In the cocrystal structures of 
VanX and ghosphinate or n-Ala-D-Ala, there is no residue 
within 8.0 A of the phosphinyl or carbonyl group that could 
deprotonate the water nucleophile other than Glu181 
(3.3 A; absolutely required for catalysis [23]) and the car- 
boxylate group of the substrate (3.3 A), favoring the zinc- 
hydroxide mechanism (Figure 7). Furthermore this residue 
is totally conserved in all VanX homologs identified to date 
[17]. In the present work we show that the Serl14 sidechain 
plays an important role in substrate recognition given the 
ZOOO-fold increase in K,, in the Serl14-+Ala mutant. For a 
reverse-protonation mechanism involving the carboxylate 
group of the D-Ala-D-Ala substrate as the catalytic base 
such as has been proposed for the carboxypeptidase A [32], 
one would expect both kinetic parameters (not just on K,,) 
to be affected in the Serl14-+Ala mutant. The overall con- 
servation of critical residues for recognition and catalytic 
activity between VanX, \‘anY and Ddp suggest a similar 
reaction mechanism for these enzymes as well. 
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Figure 7 
Arg71 
Arg71 
Chem&y & Biology 
Proposed mechanism of VanX. The water molecule is activated by 
Glul81 and attacks the zinc-polarized carbonyl to form a tetrahedral 
intermediate stabilized by both the zinc atom and Arg71. Glul81 
transfers the proton to the nitrogen that is hydrogen bonded to the 
carbonyl group of TyrlO9; peptide-bond cleavage follows. A similar 
reaction mechanism has been proposed for thermolysin [28] and 
carboxypeptidase A [311. 
Significance 
The metallodipeptidase VanX plays an essential role in 
pathogenic vancomycin-resistant enterococci (VRE) by 
selectively depleting the cellular pool of D-Ala-D-Ala over 
D-Ala-D-lactate during reprogramming of cell wall 
biosynthesis to new peptidoglycan precursors terminating 
in D-Ala-D-lactate. There has been substantial interest in 
deciphering the mechanism, substrate specificity and 
three-dimensional structure of VanX, given that metallo- 
proteases operating in other biological contexts, such as 
angiotensin converting enzyme have been successfully 
targeted for therapeutic intervention. We report here 
results from mutagenesis studies that support structure- 
based functional predictions and explain why the VanX 
dipeptidase and Ddl ligase enzymes show dramatic speci- 
ficity for the small D,D-dipeptide substrate. The compact 
active sites and strict discrimination for small substrate 
ligands put constraints on inhibitor development for both 
VanX and the D-,D-ligase Ddl and the VRE D-,D-ligase 
counterpart VanA. This work shows similar architec- 
tural solutions to substrate recognition and acceleration 
of catalysis by two enzymes that use the same substrate 
but run in different directions driven by distinct cofactors 
(zinc versus ATP). We also identify conserved active-site 
residues in the VRE D-Ala-D-Ala carboxypeptidase 
VanY that predict a similar reaction mechanism and cat- 
alytic architecture to the VanX enzyme. 
Materials and methods 
Materials 
Bacteriological media were obtained from Difco Laboratories. The 
competent E. co/i strain BL21 (DE3) [F-, ompT, hsdS,, (r,..,m,-), gal, 
dcm, (DE3)] was purchased from Novagen. Competent E. co/i strain 
DH5o [F-, $8Od/acZAM15, A(/acZYA-argF)U169, deoR, recA1, 
endAl, hsdR17(+, mk+), phoA, supE44, y, thi-1, gyrA96, reelAl was 
purchased from GibcoBRL. Restriction endonucleases, T4 DNA ligase, 
calf intestinal alkaline phosphatase, and amylose resin were obtained 
from New England Biolabs. Pfu DNA polymerase was purchased from 
Stratagene. Isopropyl-l -thio-P-D-galactopyranoside (IF’TG) was pur- 
chased from Bachem Biosciences. Kanamycin, D-Ala-o-Ala and 
N-acetylbo-Ala-o-Ala were purchased from Sigma. o-lactyl-D-Ala has 
been synthesized previously in this laboratory [24]. Chelex-100 resin 
and low molecular weight markers for polyacrylamide gel electrophore- 
sis (PAGE) were obtained from Bio-Rad. Plasmid plADLl4 expressing 
the vanX gene from type A vancomycin resistant enterococci has been 
described previously [23]. 
Recombinant DNA methods 
Recombinant DNA techniques were performed as described else- 
where [341. Preparation of plasmid DNA, gel purification of DNA frag- 
ments, and purification of polymerase chain reaction (PCR)-amplified 
DNA fragments [35,361 were performed using the CIAprepe spin 
plasmid miniprep kit, QIAEXs II gel extraction kit and QIAquick”” PCR 
purification kit, respectively (QIAGEN). PCRs were carried out as 
described by Lessard and Perham [371, using the pfu DNA poly- 
merase. Splicing by overlap extension (SOE) reactions [38] were 
carried out as for the PCR using approximately an equimolar ratio (total 
amount -50 ng) of each of the gel-purified PCR-amplified DNA frag- 
ments to be joined as template. The fidelity of the SOE- or PCR-ampli- 
fied DNA fragments was established by nucleotide sequencing after 
subcloning into the expression vector. Oligonucleotide primers were 
obtained from Integrated DNA Technologies, and DNA sequencing 
was performed on double-stranded DNA by the Molecular Biology 
Core Facility of the Dana Farber Cancer Institute (Boston, MA). 
Site-directed mutagenesis 
Site-directed mutants Serl14-+Ala and Serll5AAla were constructed 
from a plADLl4 template by PCR mutagenesis using the primer pairs 
2044/l 134 and 2044/l 136, respectively (Table 3). The purified 
PCR-amplified DNA fragments were digested with Ndel and Sacll, 
gel-purified and subcloned into plADLl4. Site-directed mutants Tyr21+ 
Phe, Tyr35+Phe, AspBB+Ala, Asp68+Asn, Arg71 -+Ala, Arg71jHi.s 
Arg7 1 -+Lys, Asp1 42-+Ala and Asp1 42-+Asn were constructed using 
the SOE method. In the first round of PCR, the sequences upstream and 
downstream of the mutation were amplified separately using a plADLl4 
plasmid template and the primer pairs 2044/l 1 XX and 21Xx/l 101, 
respectively, for all mutants except for the Asp1 42 mutants, which were 
amplified using the primer pairs 2001/l 1Xx and 21XX/RSRP, respec- 
tively (Table 3; each mutant corresponds to a particular XX pair of 
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Table 3 
Oligonucieotide primers for site-directed mutagenesis. 
Comment Code 5’-3’ Nucleotide sequence 
MB”,,,, 
VanXlntRD145A 
VanXlntF 
T7,eml 
Tvr21 +Phe 
Tir21 +Phe 
Tyr35+Phe 
Tyr35+Phe 
Asp68+Ala 
Asp68+Ala 
Asp68-+Asn 
Asp68+Asn 
Arg7 1 +Ala 
Arg71 +Ala 
Arg71 +His 
Arg7l+His 
Arg71 -+Lys 
Arg71 -+Lys 
Serll4-tAla 
Serl 15-+Ala 
Asp1 42-+Ala 
Asp1 42+Ala 
Asp1 42-+Asn 
Asp1 42+Asn 
2044 CCTGAAAGACGCGCAGACTAATTCG 
1101 AGAGCGTTCAOCCATAAAATCWIATC 
2001 ACTGTTTTATGCAATGGGCTGC 
RSRP CGTGAACCATCACCCTAATCAAG 
2126 GGACGCTZ'AATTTGCCACTTGG 
1126 CCAAGTGGCAAATTTAGCGTCC 
2127 GGTTGACGGTTZTGAAGTAAATCG 
1127 CGATTTACTTCAA?+ACCGTCAACC 
2122 GCTTCTATGGGCAGGTTACCGTCCTAAGC 
1122 GGACGGTAACCTGCCCATAGAAGCAATCC 
2123 GCTTCTATGGAACGGTTACCGTCCTAAGC 
1123 GGACGGTAACCGTECATAGAAGCAATCC 
2128 GGACGGTTACGCKCTAAGCGTGC 
1128 GCACGCTTAGGAGCGTAACCGTCCC 
2129 GGACGGTTACCATCCTAAGCGTG 
1129 GCACGCTTAGGAZGGTAACCGTCCC 
2130 GGACGGTTACMOCCTAAGCGTGCT 
1130 GCACGCTTAGGCTlGTAACCGTCCC 
1134 GGCACTGCCGCGGCTATGGCTTGC'I'TTTGAAGCCACG 
1136 GGCACTGCCGCGGCTATGGGJCTGATTTTGUIGCCACG 
2124 CGATTTGCCTTTATGGATGAACG 
1124 GTTCATCCATX-bX!5ZAAATCGGCTCC 
2125 CGATTTAACTTTATGGATGAACG 
1125 GTTCATCCATAAAOTTAAATCGGCTCC 
Mismatch mutations are bold and italicized. 
primers). The resulting PCR-amplified DNA fragments were gel purified 
and subjected to a second round of PCR using the 2044/l 101 primer 
pair for all mutants except for the Asp142 mutants, in which the PCRs 
were performed using the 200l/RSRP primer pair. The purified 
SOE-amplified DNA fragment was digested with Sacll and HindIll for the 
Asp1 42 mutants and Ndel and Sacll for the remaining mutants, gel puri- 
fied and subcloned into a plADLl4. 
Overproduction and purification of the MBP-VanX fusion 
mutants 
Overexpression was performed as described in McCafferty et a/. [23]. 
Purification was performed as described previously [17]. The yield of 
pure MBP-VanX protein obtained from 1 I culture of induced f. co/i 
BL21 (DE3) cells was -40 mg. 
Protein quantitation and SDS-polyacrylamide gel 
electrophoresis 
Concentration of pure protein was determined by UV-visible spec- 
troscopy and extinction coefficients (Earn, 1 18,720 M-‘cm-’ for all 
mutants, except TyrPl+Phe and Tyr35dPhe for which &280 was 
1 17,230 M-‘cm-‘) were calculated based on a modification of the 
Edelhoch method [39,40]. Proteins were separated by SDS-PAGE 
using a discontinuous Tris/giycine buffer [41] with loo/, acrylamide 
resolving gels and 5010 acrylamide stacking gels containing 0.1 O/o SDS. 
Enzyme activity 
Enzyme activity was measured in 50 mM Tris (pH 8.0) at 37°C accord- 
ing to published procedures [14] using the modified cadmium-ninhy- 
drin assay method, which detects the production of free o-Ala [421. 
Acknowledgements 
We are grateful to Abbott Laboratories for providing the coordinates of the 
enterococcal VanX crystal structure and particularly to Dirk Bussiere for his 
input on interpretation of the activity of the mutants proteins. We also thank 
Roger Flugel for help with the figures generated with the programs GRASP 
and Quanta and Dewey McCafferty and members of the Walsh laboratoty for 
insightful discussions. I.A.D.L. acknowledges the Medical Research Council of 
Canada for Postdoctoral Fellowshtp support. This research was supported 
in part by a grant from Abbott Laboratories and by NIH GM21 643. 
References 
1. 
2. 
Neu, H.C. (1992). The crisis in antibiotic resistance. Science 
257, 1064-1073. 
3. 
4. 
5. 
6. 
7. 
6. 
9. 
10. 
11 
12 
Tomasz, A. (1994). Multiple-antibiotic-resistant pathogenic bacteria. 
A report on the Rockefeller University Workshop. N. En.ql. J. Med. 
330: 1247-1251. 
Swartz, M.N. (1994). Hospital-acquired infections: diseases with 
increasingly limited therapies. Proc. Nat/ Acad. SC;. USA 
91, 2420-2427. 
Kirst, H.A., Thompson, D.G. & Nicas, T.I. (1998). Historical yearly usage 
of vancomycin. Antimicrob. Agents Chemother. 42, 1303-l 304. 
Leclercq, R. & Courvalin, P. (1997). Resistance to glycopeptides in 
enterococci. C/in. infect. Dis. 24, 545-554. 
Murray, E. (1997). Vancomycin-resistant enterococci. Am. J. Med. 
102, 284-293. 
Cunha, B.A. (1995). Vancomycin. Med. C/in. N. Am. 19, 817-831. 
Arthur, M. & Courvalin, P. (1993). Genetics and mechamsms of 
glycopeptlde resistance in enterococci. Antimicroob. Agents 
Chemother. 37, 1563-l 571. 
Arthur, M., Molinas, C., Depardieu, F. & Courvalm. P. (1993). 
Characterization of Tn 7546, a Tn3-related transposon conferring 
glycopeptlde resistance by synthesis of depsipeptide peptidoglycan 
precursors in fnterococcus faecium BM4147. 1. Bacterial. 
175, 117-l 27. 
Walsh, CT., Fisher, S.L., Park, I.-S., Prahalad, M. & Wu, Z. (1996). 
Bacterial resistance to vancomycin: five genes and one missing 
hydrogen bond tell the story. Chem. B/o/. 3, 21-28. 
Bugg, T.D.H., Wright, G.D., Dutka-Malen, S., Arthur, M., Courvalin, P. 
&Walsh, C.T. (1991). Molecular basis for vancomycin resistance in 
Entefococcus faecium BM4147: biosynthesis of a depsipeptide 
peptidoglycan precursor by vancomycin resistance protetns VanH and 
VanA. Biochemistry 30, 10408-l 0415. 
Arthur, M., Molinas, C. & Courvalin, P. (1992). The Vans-VanR two- 
component regulatory system controls synthesis of depsipeptide 
peptidoglycan precursors In Enterococcus faecium BM4147. 
J. Bacterial. 174, 2582-2591. 
Research Paper Mutational analysis of Van X active-site residues Lessard and Walsh 187 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
26. 
27. 
28. 
29. 
30. 
31. 
32. 
33. 
34. 
Reynolds, P.E., Depardieu, F., Dutka-Malen, S., Arthur, M. & 
Courvalin, P. (1994). Glycopeptide resistance mediated by 
enterococcal transposon Tnl546 requires production of VanX for 
hydrolysis of D-alanyl-p-alanine. Mol. Microbial. 13, 1065-I 070. 
Wu, Z., Wright, G.D. &Walsh, C.T. (1995). Overexpression, 
purification, and characterization of VanX, a D;D-dipeptidase which is 
essential for vancomycin resistance in Enterococcus faecium 
BM4147. Biochemistry 34, 2455-2463. 
Reynolds, P.E. (1998). Control of peptidoglycan synthesis in 
vancomycin-resistant enterococci: D,D-peptidases and 
D,D-carboxypeptidases. Cell Mol. Life SC;. 54, 325-331. 
Marshall, C.G., Lessard, I.A.D., Park, I.-S. &Wright, G.D. (1998). 
Glycopeptide antibiotic genes in glycopeptide-producing organisms. 
Antimicrob. Agents Chemother. 42, 2215-2220. 
Lessard, I.A.D. et al., & Walsh, C.T. (1998). Homologs of the 
vancomycin resistance D-Ala-D-Ala dipeptidase VanX in Streptomyces 
toyocaensis, Escherichia co/i and Synechocystis: attributes of 
catalytic efficiency, stereoselectivity and regulation with implications 
for function. Chem. i3iol. 5,469.504. 
Marshall, C.G. &Wright, G.D. (1997). The glycopeptide antibiotic 
producer Streptomyces toyocaensis NRRL 15009 has both D-afanyf- 
D-afanine and D-alar@D-iaCtate ligases. EMS Micriobiol. Left. 
157, 295-299. 
Bussiere, D.E., Pratt, S.D., Katz, L. Severin, J.M., Holzman, T. & 
Park, C. (1998). The structure of VanX reveals a novel amino- 
dipeptidase involved in mediating transposon-based vancomycin 
resistance. Mol. CeN 2, 75-84. 
Fan, C., Moews, P.C., Walsh, CT. & Knox, J.R. (1994). Vancomycin 
resistance: structure of D-afanine-D-aianine ligase at 2.3 A resolution. 
Science 266, 439-443. 
Dideberg, O., Charlier. P., Dive, G., Joris, B., Frere, J.M. & Ghuysen, 
J.M. (1982). Structure of a Zn2+- containing D-alanyl-D-alanine-CleaVing 
carboxypeptidase at 2.5 A resolution. Nature 299, 469-470. 
Wu, Z. &Walsh, CT. (1995). Phosphinate analogs of D-,D- 
dipeptides: slow-binding inhibition and proteolysis protection of VanX, 
a D-,D-dipeptidase required for vancomycin resistance in 
Enterococcus faecium. Proc. Nat/ Acad. SC;. USA 92, 11603-l 1607. 
McCafferty, D.G., Lessard, I.A.D. &Walsh, CT. (1997). Mutational 
analysis of potential zinc-binding residues in the active site of the 
enterococcal D-Ala-o-Ala dipeptidase VanX. Biochemistry 
36, 10498-l 0505. 
Park, I.-S., Lin, C.H. & Walsh, CT. (1996). Gain of D-alanyj-D-lactate 
or D-dactyl-D-ajanine synthetase activities in three active-site mutants 
of the Escherichia co/i D-alanyf-D-alanine ligase B. Biochemistry 
35, 10464-l 0471. 
Shi, Y. & Walsh, CT. (1995). Active site mapping of Escherichia co/i 
o-Ala-D-Ala ligase by structured-based mutagenesis. Biochem/stry 
34, 2786-2776. 
Arthur, M., Depardieu, F., Cabanie, L., Reynolds, P. & Courvalin, P. 
(1998). Requirement of the VanY and VanX D,D-peptidases for 
glycopeptide resistance in enterococci. Antimicrob. Agents 
Chemother. 36, 1514-1518. 
Wright, G.D., Molinas, C., Arthur, M., Courvalin, P., &Walsh, C.T. 
(1992). Characterization of VanY, a D,D-carboxypeptidase from 
vancomycin-resistant Enterococcus faecium BM4147. Antimicrob. 
Agents Chemother. 36, 1514-l 518. 
Holden, H.M., Tronrud, D.E., Monzingo, A.F., Weaver, L.H. & 
Matthews, B.W. (1987). Slow- and fast-binding inhibitors of 
thermolysin display different modes of binding: crystallographic 
analysis of extended phosphonamidate transition-state analogues. 
Biochemistry 26,8542-8553. 
Izquierdo-Martin, M. & Stein, R.L. (I 992). Mechanistic studies on the 
inhibition of thermolysin by a peptide hydroxamic acid. J. Am. Chem. 
Sot. 114, 325-331. 
Mock, W.L. & Stanford, D.J. (1996). Arazoformyl dipeptide substrates 
for thermolysm. Confirmation of a reverse protonation catalytic 
mechanism. Biochemistry 35, 7369-7377. 
Christianson, D.W. & Lipscomb, W.N. (1989). Carboxypeptidase A. 
Accounts Chem. Res. 22,62-69. 
Mock, W.L. & Zhang, J.Z. (1991). Mechanistically significant 
diastereoselection in the sulfoximine inhibition of carboxypeptidase A. 
1. fliol. Chem. 266, 6393-6400. 
Lipscomb, W.N. & Strater, N. (1996). Recent advances in zinc 
enzymology. Chem. Rev. 96, 2375-2433. 
Sambrook, J. Fritsch, E.F. & Maniatis, T. (1969). Molecular Cloning: A 
Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory, Cold 
Spring Harbor, NY. 
35. 
36. 
37. 
38. 
39. 
40. 
41. 
42. 
43. 
44. 
Saiki, R.K., et al., & Arnheim, N. (1985). Enzymatic amplification of 
beta-globin genomic sequences and restriction site analysis for 
diagnosis of sickle cell anemia. Science 230, 1350-l 354. 
Saiki, R.K., et al., & Erlich, H.A. (1988). Primer-directed enzymatic 
amplification of DNA with a thermostable DNA polymerase. Science 
239, 487-491. 
Lessard, I.A.D. & Perham, R.N. (1994). Expression in Eschenchia co/i 
of genes encoding the Ela and El 8 subunits of the pyruvate 
dehydrogenase complex of Bacillus stearothermophilus and assembly 
of a functional El component (a2 p2) in vitro. J. Biol. Chem. 
269, 10378-l 0383. 
Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K. &Pease, L.R. (1989). 
Sate-directed mutagenesis by overlap extension using the polymerase 
chain reaction. Gene 77, 51-59. 
Edelhoch, H. (1967). Spectroscopic determination of tryptophan and 
tyrosine in proteins. Biochemistry 6, 1946-l 954. 
Pace, C.N., Vajdos, F. Fee, L., Grimsley, G. & Gray, T. (1995). How to 
measure and predict the molar absorption coefficient of a protein. 
Protein SC;. 4, 241 l-2423. 
Laemmli, U.K. (1970). Cleavage of structural proteins during the 
assembly of the head of bacteriophage T4. Nature 227, 680-665. 
Doi, E., Shibata, D. & Matoba, T. (1981). Modified calorimetric 
ninhydrin methods for peptidase assay. Anal. Biochem. 116, 173-I 84. 
Nicholls, A., Sharp, K.A. & Honig, B. (1991). Protein folding and 
association: insights from the interfacial and thermodynamic 
properties of hydrocarbons. Proteins 11, 57-68. 
Thompson, J.D., Higgins, D.G. & Gibson, T.J. (1994). CLUSTAL W: 
improving the sensibility of progressive multiple sequence alignment 
through sequence weighting, position-specific gap penalties and 
weight matrix choice. Nucleic Acids. Res. 22, 4673-4680. 
Because Chemistry & Biology operates a ‘Continuous 
Publication System’ for Research Papers, this paper has been 
published via the internet before being printed. The paper can 
be accessed from http://biomednet.wmkbiology/cmb - for 
further information, see the explanation on the contents pages. 
